Core Alternative Capital Enovis Corp Call Options Transaction History
Core Alternative Capital
- $484 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENOV
# of Institutions
301Shares Held
61.6MCall Options Held
1.63MPut Options Held
576K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.64MShares$287 Million0.19% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$235 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$231 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.15MShares$136 Million0.04% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$130 Million0.54% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.34B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...